Moreover, upon inhibition of COL6A3, the expression of the PI3K/AKT pathway-related markers changed significantly, suggesting a crucial role for COL6A3 in modulating various aspects of the progression of osteosarcoma, which would provide a potentially effective treatment for osteosarcoma [43]. This evidence concerns the gene COL6A3 and osteosarcoma.